Follow
Yihui Song
Yihui Song
Associate Professor, School of Pharmaceutical Sciences, ZhengZhou University
Verified email at zzu.edu.cn
Title
Cited by
Cited by
Year
Indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
K Tang, YH Wu, Y Song, B Yu
Journal of Hematology & Oncology 14, 1-21, 2021
1902021
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
Y Song, M Zhao, H Zhang, B Yu
Pharmacology & therapeutics 230, 107966, 2022
652022
Strategies targeting protein tyrosine phosphatase SHP2 for cancer therapy
Y Song, S Wang, M Zhao, X Yang, B Yu
Journal of Medicinal Chemistry 65 (4), 3066-3079, 2022
472022
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021
Y Song, H Zhang, X Yang, Y Shi, B Yu
European Journal of Medicinal Chemistry 228, 114042, 2022
292022
A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors
Y Song, M Zhao, Y Wu, B Yu, HM Liu
Acta Pharmaceutica Sinica B 11 (3), 750-762, 2021
262021
Repurposing antidepressants for anticancer drug discovery
Y Song, X Yang, B Yu
Drug discovery today 27 (7), 1924-1935, 2022
232022
Brønsted acid-promoted ‘on–water’C (sp3)-H functionalization for the synthesis of isoindolinone/[1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives targeting the SKP2-CKS1 …
S Yuan, S Wang, M Zhao, D Zhang, J Chen, JX Li, J Zhang, Y Song, ...
Chinese Chemical Letters 31 (2), 349-352, 2020
212020
Structural insights into the CRTC2–CREB complex assembly on CRE
Y Song, L Zhai, JV Swain, Y Chen, P Wang, L Chen, Y Liu, S Xiang
Journal of molecular biology 430 (13), 1926-1939, 2018
212018
Crystallographic landscape of SHP2 provides molecular insights for SHP2 targeted drug discovery
Y Song, X Yang, S Wang, M Zhao, B Yu
Medicinal Research Reviews 42 (5), 1781-1821, 2022
172022
Harnessing the cyclization strategy for new drug discovery
K Tang, S Wang, W Gao, Y Song, B Yu
Acta Pharmaceutica Sinica B 12 (12), 4309-4326, 2022
152022
Recent advances of LSD1/KDM1A inhibitors for disease therapy
C Zhang, Z Wang, Y Shi, B Yu, Y Song
Bioorganic Chemistry 134, 106443, 2023
72023
Structural and functional landscape of FAD-dependent histone lysine demethylases for new drug discovery
Y Song, S Wang, B Yu
Journal of Medicinal Chemistry 66 (1), 71-94, 2022
72022
Structure-based design, synthesis and biological evaluation of aminopyrazines as highly potent, selective, and cellularly active allosteric SHP2 inhibitors
K Tang, M Zhao, YH Wu, Q Wu, S Wang, Y Dong, B Yu, Y Song, HM Liu
European Journal of Medicinal Chemistry 230, 114106, 2022
62022
Combining EGFR inhibitors with SHP2 or LSD1 inhibitors to overcome multidrug resistance in cancer
H Zhang, X Yang, Y Song, B Yu
Future Medicinal Chemistry 14 (8), 527-529, 2022
42022
KRAS Q61H mutation confers cancer cells with acquired resistance to SHP2 inhibition
YH Song, XY Yang, B Yu
Pharmaceutical Fronts 4 (01), e40-e42, 2022
32022
Targeting SHP2 for Cancer Treatment: Advances and Prospects
Y Song, B Yu
Handbook of Cancer and Immunology, 1-19, 2023
22023
Emerging therapeutic approaches of SHP2-targeted modulators
X Yang, J Xiong, B Yu, Y Song
Future Medicinal Chemistry 16 (4), 291-294, 2024
12024
Discovery and pharmacodynamic evaluation of the novel butene lactone derivative M355 against influenza A virus in vitro and in vivo
J Geng, X Hu, Z Zhang, Z Gu, Y Li, X Mou, L Mao, Y Ge, X Yang, Y Song, ...
Journal of Medical Virology 94 (9), 4393-4405, 2022
12022
Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor
K Tang, S Wang, S Feng, X Yang, Y Guo, X Ren, L Bai, B Yu, HM Liu, ...
Acta Pharmaceutica Sinica B, 2024
2024
Development of a robust HTRF assay with USP7 full length protein expressed in E. coli prokaryotic system for the identification of USP7 inhibitors
Y Song, S Wang, M Zhao, B Yu
Journal of Pharmaceutical and Biomedical Analysis 227, 115305, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20